title: Anti-epileptic prophylaxis in traumatic brain injury: A retrospective analysis of patients undergoing craniotomy versus decompressive craniectomy.
abstract: BACKGROUND
  Seizures account for significant morbidity and mortality early in the course of traumatic brain injury (TBI). Although there is sufficient literature suggesting short-term benefits of antiepileptic drugs (AEDs) in post-TBI patients, there has been no study to suggest a time frame for continuing AEDs in patients who have undergone a decompressive craniectomy for more severe TBI. We examined trends in a level-II trauma center in southern California that may provide guidelines for AED treatment in craniectomy patients.
  
  
  METHODS
  A retrospective analysis was performed evaluating patients who underwent decompressive craniectomy and those who underwent a standard craniotomy from 2008 to 2012.
  
  
  RESULTS
  Out of the 153 patients reviewed, 85 were included in the study with 52 (61%) craniotomy and 33 (39%) craniectomy patients. A total of 78.8% of the craniotomy group used phenytoin (Dilantin), 9.6% used levetiracetam (Keppra), 5.8% used a combination of both, and 3.8% used topiramate (Topamax). The craniectomy group used phenytoin 84.8% and levetiracetam 15.2% of the time without any significant difference between the procedural groups. Craniotomy patients had a 30-day seizure rate of 13.5% compared with 21.2% in craniectomy patients (P = 0.35). Seizure onset averaged on postoperative day 5.86 for the craniotomy group and 8.14 for the craniectomy group. There was no significant difference in the average day of seizure onset between the groups P = 0.642.
  
  
  CONCLUSIONS
  Our study shows a trend toward increased seizure incidence in craniectomy group, which does not reach significance, but suggests they are at higher risk. Whether this higher risk translates into a benefit on being on AEDs for a longer duration than the current standard of 7 days cannot be concluded as there is no significant difference or trend on the onset date for seizures in either group. Moreover, a prospective study will be necessary to more profoundly evaluate the duration of AED prophylaxis for each one of the stated groups.
authors: Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, California, USA.
authors: Vivek
authors: V
authors: Ramakrishnan
authors: Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, California, USA.
authors: Robert
authors: R
authors: Dahlin
authors: Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, California, USA.
authors: Omid
authors: O
authors: Hariri
authors: Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, California, USA.
authors: Syed A
authors: SA
authors: Quadri
authors: Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, California, USA.
authors: Saman
authors: S
authors: Farr
authors: Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, California, USA.
authors: Dan
authors: D
authors: Miulli
authors: Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, California, USA.
authors: Javed
authors: J
authors: Siddiqi
keywords: Craniotomy; craniectomy; levetiracetam; phenytoin; seizure; topiramate; traumatic brain injury
references: J Neurotrauma. 2007;24 Suppl 1:S83-6
references: 17511552
references: J Neurosurg. 1983 May;58(5):672-7
references: 6339686
references: J Neurosurg. 1999 Oct;91(4):588-92
references: 10507379
references: JAMA. 1991 Mar 13;265(10):1271-7
references: 1995974
references: Neurology. 1980 Jul;30(7 Pt 1):683-9
references: 7190235
references: J Neurol Neurosurg Psychiatry. 1971 Feb;34(1):106
references: 5551680
references: J Neurosurg. 2011 Jul;115(1):124-9
references: 21438659